New High-Throughput Platform Uses Peptide Barcodes to Screen Thousands of Cell-Penetrating Peptides at Once | Research

The takeaway

BarcodeBabel and PeptideBabel — new open-source tools — enable high-throughput screening of cell-penetrating peptide libraries by tagging each CPP with a unique mass-spectrometry-readable barcode, identifying variants that deliver hundreds of millions of molecules per cell.

Hundreds of millions of molecules per cell
delivered by top CPPs identified through barcoded library screening — with minimal membrane disruption and negligible toxicity

What the researchers found

The BarcodeBabel/PeptideBabel platform enabled high-throughput screening of CPP libraries via mass spectrometry barcoding, identifying cell-penetrating peptides that delivered hundreds of millions of molecules per cell with minimal toxicity.

Why it matters

Drug delivery is the biggest bottleneck for therapeutic peptides and proteins. Traditional CPP screening is slow (one peptide at a time), but this barcoding approach screens entire libraries simultaneously. By dramatically accelerating CPP discovery, it could speed the development of intracellular delivery solutions for biologics, gene therapies, and other macromolecular drugs.

The numbers in context

BarcodeBabel generates libraries of unique peptide barcodes; PeptideBabel uses Monte Carlo sampling for design optimization.

How the study worked

Developed BarcodeBabel for designing mass-spectrometry-compatible peptide barcode libraries. Created PeptideBabel using Monte Carlo sampling for CPP design with varied physicochemical properties. Screened barcoded CPP libraries using quantitative targeted mass spectrometry. Measured nuclear and cytoplasmic delivery, membrane disruption, and cytotoxicity in vitro.

Who was studied

Technology platform development for drug delivery screening

What this study cannot tell us

In vitro proof-of-concept — top CPPs haven't been validated in vivo. Mass spectrometry-based readout requires specialized equipment. The barcoding approach measures total peptide delivered but doesn't distinguish between different intracellular compartments beyond nucleus vs. cytoplasm. Library diversity is constrained by barcode design rules.

How to read the evidence

Preliminary — in vitro proof-of-concept demonstrating the screening platform. The CPPs identified need in vivo validation. The methodology itself is novel and well-validated.

When this study was published

Published in 2024, introducing a novel high-throughput approach to CPP discovery with open-source tools.

The bigger picture

This platform represents a paradigm shift in peptide screening — from sequential testing to massively parallel evaluation. The approach isn't limited to CPPs; it could be adapted to screen any peptide library for any property measurable by mass spectrometry. As biologics and gene therapies increasingly dominate drug development, efficient intracellular delivery screening becomes ever more critical.

Questions still open

Do the top-performing CPPs identified through barcoding maintain their delivery efficiency in vivo?
Can this platform be scaled to screen tens of thousands of CPP variants simultaneously?
Could BarcodeBabel be adapted to screen peptide libraries for properties beyond cell penetration, such as receptor binding or enzyme inhibition?

Common questions

What is peptide barcoding and why does it matter?

Imagine testing 100 different keys on a lock, but instead of trying them one at a time, you try all 100 simultaneously and each key leaves a unique fingerprint when it enters. That's essentially what peptide barcoding does — each cell-penetrating peptide carries a unique molecular tag that mass spectrometry can read, so researchers can test an entire library of peptides on cells at once and immediately know which ones got inside and how much of each made it in.

Why is getting drugs inside cells so difficult?

Cell membranes are designed to keep foreign molecules out. Large therapeutic molecules like proteins, antibodies, and gene therapies are too big to simply diffuse through the membrane. Cell-penetrating peptides can ferry these large molecules across the membrane, but finding the right CPP for each cargo has been slow trial-and-error work. This barcoding platform dramatically speeds up that search.

Read the original research

Proteomic Barcoding Platform for Macromolecular Screening and Delivery.

Journal of proteome research, 23(6), 2067-2077

View on PubMed ↗Publisher’s paper ↗

Citation

Wang, Ning; Mcneer, Nicole A; Eton, Elliot; Fass, Josh; Kentsis, Alex. (2024). Proteomic Barcoding Platform for Macromolecular Screening and Delivery.. Journal of proteome research, 23(6), 2067-2077. https://doi.org/10.1021/acs.jproteome.4c00068